Denmark clinical marijuana sales publish a favorable quarter many thanks to Epidiolex

Denmark medical cannabis, Denmark medical cannabis sales post a positive quarter thanks to Epidiolex


A longer variation of this tale shows up at Cannabis Service Daily International.

Sales of clinical cannabis in Denmark uploaded healthy and balanced gains in the 3rd quarter of 2020, accompanying the launch of GW Pharmaceuticals’ CBD medication Epidiolex.

General sales of all median marijuana items expanded from regarding 13 million Danish Krones ($ 2 million) in the 2nd quarter to virtually 16 million Danish Krones in the 3rd quarter, standing for a gain of greater than 20%.

Yet earnings within the nation’s pilot program, which permits sales of blossom as well as oil without advertising permission, continues to be tiny as well as much from the height seen one year earlier.

In the 3rd quarter of 2020, just 12.5% of overall earnings produced by clinical marijuana sales originated from items marketed as component of the pilot program, main information programs.

That is below very early 2019, when deals in the pilot program stood for 40% of the overall clinical marijuana sales.

The largest adjustment from the previous quarter was a significant rise of sales in the group of ended up pharmaceutical items with advertising permission, clarified by the begin of GW Pharmaceuticals’ Epidiolex sales.

The group of magistral prep work– medications prepared in a drug store from separated THC and/or CBD– reduced accompanying the begin of Epidiolex sales, an indicator that some CBD prescriptions switched over from magistral prep work to Epidiolex, an ended up pharmaceutical item.

Bookkeeping for all clinical marijuana items, overall sales throughout the 3rd quarter had to do with 15.7 million Danish krone, of which:

  • The pilot program stood for just 12.5% of the total amount.
  • Magistral prep work with pure THC or pure CBD– no full-spectrum items– represented virtually half of all sales.
  • A 3rd of the sales represented end up pharmaceutical items with advertising permission. Nearly all the earnings in this group was produced by Epidiolex sales, which began in mid-2020; the remainder are attributable to GW Pharmaceuticals’ various other signed up medication, Sativex.
  • The continuing to be 6% represented various other ended up pharmaceutical items that do not have advertising permission in Denmark, primarily UNITED STATE Food as well as Medicine Administration-approved Marinol.
READ ALSO  Biden Administration Calls on DEA to Transfer Marijuana to Schedule 3

Thinking about all kinds of items, 6,130 people got a prescription for clinical marijuana a minimum of as soon as from January 2018 up until September 2020– most for separated cannabinoids magistral prep work.

Alfredo Pascual can be gotten to at [email protected]

Denmark medical cannabis, Denmark medical cannabis sales post a positive quarter thanks to Epidiolex


The declarations made worrying these items have not been assessed by the Cuisines as well as Medicine Management. The efficiency of those product has actually not been verified by FDA-approved evaluation. These goods are typically not suggested to detect, handle, treatment, or avert any kind of disease. All information discovered right below will certainly not be suggested as an alternate option to or various from information from wellness treatment experts. Please look for the suggestions of your wellness treatment experienced regarding prospective communications or various possible problems previously than using any kind of item. The Federal Cuisines, Medicine as well as Elegance Act needs this exploration.